Victoria Wangia1, Theresa I Shireman. 1. University of Kansas Medical Center, Kansas City, Kansas, United States. Electronic address: vwangia@gmail.com.
Abstract
BACKGROUND: While understanding geography's role in healthcare has been an area of research for over 40 years, the application of geography-based analyses to prescription medication use is limited. The body of literature was reviewed to assess the current state of such studies to demonstrate the scale and scope of projects in order to highlight potential research opportunities. OBJECTIVE: To review systematically how researchers have applied geography-based analyses to medication use data. METHODS: Empiric, English language research articles were identified through PubMed and bibliographies. Original research articles were independently reviewed as to the medications or classes studied, data sources, measures of medication exposure, geographic units of analysis, geospatial measures, and statistical approaches. RESULTS: From 145 publications matching key search terms, forty publications met the inclusion criteria. Cardiovascular and psychotropic classes accounted for the largest proportion of studies. Prescription drug claims were the primary source, and medication exposure was frequently captured as period prevalence. Medication exposure was documented across a variety of geopolitical units such as countries, provinces, regions, states, and postal codes. Most results were descriptive and formal statistical modeling capitalizing on geospatial techniques was rare. CONCLUSION: Despite the extensive research on small area variation analysis in healthcare, there are a limited number of studies that have examined geographic variation in medication use. Clearly, there is opportunity to collaborate with geographers and GIS professionals to harness the power of GIS technologies and to strengthen future medication studies by applying more robust geospatial statistical methods.
BACKGROUND: While understanding geography's role in healthcare has been an area of research for over 40 years, the application of geography-based analyses to prescription medication use is limited. The body of literature was reviewed to assess the current state of such studies to demonstrate the scale and scope of projects in order to highlight potential research opportunities. OBJECTIVE: To review systematically how researchers have applied geography-based analyses to medication use data. METHODS: Empiric, English language research articles were identified through PubMed and bibliographies. Original research articles were independently reviewed as to the medications or classes studied, data sources, measures of medication exposure, geographic units of analysis, geospatial measures, and statistical approaches. RESULTS: From 145 publications matching key search terms, forty publications met the inclusion criteria. Cardiovascular and psychotropic classes accounted for the largest proportion of studies. Prescription drug claims were the primary source, and medication exposure was frequently captured as period prevalence. Medication exposure was documented across a variety of geopolitical units such as countries, provinces, regions, states, and postal codes. Most results were descriptive and formal statistical modeling capitalizing on geospatial techniques was rare. CONCLUSION: Despite the extensive research on small area variation analysis in healthcare, there are a limited number of studies that have examined geographic variation in medication use. Clearly, there is opportunity to collaborate with geographers and GIS professionals to harness the power of GIS technologies and to strengthen future medication studies by applying more robust geospatial statistical methods.
Authors: Björn Wettermark; Brian Godman; Martin Neovius; Niklas Hedberg; Tor-Olov Mellgren; Thomas Kahan Journal: Health Policy Date: 2009-10-29 Impact factor: 2.980
Authors: Louise Pilote; Christine A Beck; Igor Karp; David Alter; Peter Austin; Jafna Cox; Karin Humphries; Cynthia Jackevicius; Hugues Richard; Jack V Tu Journal: Can J Cardiol Date: 2004-01 Impact factor: 5.223
Authors: Zachary A Marcum; Julia Driessen; Carolyn T Thorpe; Julie M Donohue; Walid F Gellad Journal: Ann Pharmacother Date: 2014-12-16 Impact factor: 3.154
Authors: Vânia Rocha; Ana Isabel Plácido; Daniela A Rodrigues; Ana Barbara Tavares; Adolfo Figueiras; Fátima Roque; Maria Teresa Herdeiro Journal: Int J Environ Res Public Health Date: 2022-10-10 Impact factor: 4.614
Authors: Michael Goodman; Judy S LaKind; Jerald A Fagliano; Timothy L Lash; Joseph L Wiemels; Deborah M Winn; Chirag Patel; Juliet Van Eenwyk; Betsy A Kohler; Enrique F Schisterman; Paul Albert; Donald R Mattison Journal: Int J Environ Res Public Health Date: 2014-01-28 Impact factor: 3.390